Circular RNA Circreps2 Acts As a Sponge of Mir-558 to Suppress Gastric Cancer Progression by Regulating RUNX3/3-catenin Signaling

Xiong Guo,Xinglong Dai,Jianjun Liu,Anqi Cheng,Chuan Qin,Ziwei Wang
DOI: https://doi.org/10.1016/j.omtn.2020.06.026
2020-01-01
Abstract:Circular RNAs (circRNAs) play an essential regulatory role in multiple cancers. However, the role of a large number of circRNAs in gastric cancer (GC) is still unknown. Here, hsa_ circ_0139996 (circREPS2), a novel circRNA that was significantly downregulated in GC, was selected for further investigation. circREPS2 was validated and analyzed by DNA sequencing and quantitative real-time PCR. The roles of circREPS2 in GC cells were verified by gainand loss-of -function experiments. Bioinformatics analysis, luciferase reporter, RNA pull-down, and RNA immunoprecipitation assays were performed to evaluate the functional mechanism of circREPS2 on microRNA-558 (miR-558)/RUNX3/beta-catenin axis in GC cells. In the present study, we found that circREPS2 was down regulated in GC tissues and cell lines. Low expression of circREPS2 was associated with a higher tumor-node-metastasis (TNM) stage, poor tumor differentiation, and larger tumor size in GC patients. Functionally, circREPS2 significantly inhibited GC cell proliferation, migration, invasion, and epithelialmesenchymal transformation (EMT) in vitro and tumorigenesis in vivo. Furthermore, our data demonstrated that circREPS2 acted as a miR-558 sponge and upregulated RUNX3 expression to inactivate beta-catenin signaling in GC cells. In conclusion, circREPS2 suppresses the progression of GC via miR-558/RUNX3/beta-catenin signaling and is a novel promising biomarker and target for GC treatment.
What problem does this paper attempt to address?